Log in
Enquire now
‌

US Patent 9630931 Pharmaceutically active pyrazine derivatives

Patent 9630931 was granted and assigned to Sentinel Oncology Limited on April, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Sentinel Oncology Limited
0
Current Assignee
‌
Sentinel Oncology Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96309310
Patent Inventor Names
Richard Justin Boyce0
Robert George Boyle0
Date of Patent
April 25, 2017
0
Patent Application Number
143586780
Date Filed
November 16, 2012
0
Patent Citations Received
‌
US Patent 11786524 Pharmaceutical compounds
Patent Primary Examiner
‌
San-Ming Hui
0
Patent abstract

The invention provides compounds which inhibit or modulate the activity of Chk-1 kinase and which are useful in the treatment of cancer. The compounds have the general formula (1):

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9630931 Pharmaceutically active pyrazine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.